Growing incidence of chronic and infectious diseases is anticipated to fuel demand for immunoassay. For example, as per a report published by the World Health Organization (WHO), in 2017, approximately 65 million individuals in the U.S. were diagnosed with Chronic Obstructive Pulmonary Disease (COPD). The factor is likely to boost regional immunoassay market.

Meanwhile, growing geriatric population across the world is anticipated to be a key driving factor for immunoassay market at global level. Owing to low immunity factor associated with old age, elderly population is more susceptible to chronic diseases and various infections.

Thus, most of diseases among arthritis, hypertension, diabetes, and dementia among others are diagnosed in elderly population.

For example, as per a report published by the United Nations, in 2017, the count of geriatric population was 962 million worldwide. The count is estimated to reach 2.1 billion by the end of 2050. This, in turn, is likely to pave potential opportunities for growth of the global immunoassay market.

Further, growing incidence of infectious diseases such as hepatitis, dengue, neurological disorders, and AIDS is a prominent factor projected to present tremendous opportunities for growth of immunoassay market over the forecast period (2018-2026).

For example, in 2017, as per data given by the WHO, approximately 5.8 million cases of severe dengue were identifies in Americans.

Rise in prevalence of such diseases is likely to provide lucrative opportunities for the prominent market players. In order to speed-up the diagnosis process, the companies operating in the global immunoassay market are focusing on development of novel immunoassay products.

The growth of the global immunoassay market largely depends on advancements in medical treatments and therapies. The healthcare industry is following a multifaceted route to cure and immunize patients against widespread infections and diseases. It is important for medical practitioners to understand the root causes of an infection in order to administer the right treatment line. Several diseases are related to the biochemical reactions going on inside the human body. Furthermore, the development of a seamless medical industry also calls for the study of biochemical reactions in the human body. There has been an increase in the incidence of infectious diseases in recent times. Medical practitioners mandate the use of macromolecular tests to understand the nature and type of disease or infection. The use of antibodies and antigens to conduct immunoassays has helped in increasing the rate of diagnosis across the medical and healthcare fraternities.

In this review, Transparency Market Research (TMR) uncovers a range of factors responsible for the growth and expansion of the global immunoassay market. The review elucidates the applications of immunoassays in key healthcare domains, creating new opportunities for market expansion. Furthermore, the segments pertaining to the immunoassay market have also been enunciated herein. It is worthwhile to understand that immunoassays can be used in various medical and healthcare verticals depending upon the type of requirement. Use of analytes, antigens, and antibodies for immunoassays has generated humongous opportunities the market players. The need for studying and quantifying analytes present in biological liquid samples such as urine or serum is felt across key domains. Immunoassays can help in achieving the aforementioned goal. The growth of the medical research fraternity across several regions shall be a launch pad for revenue generation across the market.

global immunoassay market

Use of Multiple Types of Immunoassay Markers

Medical practitioners study body proteins to analyse the reasons and causes behind the occurrence of a particular medical condition. Furthermore, the molecular composition of the human body is also analysed before administering a treatment line for critical infections. Several kinds of proteins and macromolecules can be studied through immunoassays. This factor has generated humongous opportunities for growth and expansion within the global immunoassay market. Medical professionals use several types of immunoassays that come in different formats. These immunoassays can be blended with certain reagents in order to enhance the performance of the former. Heterogeneous immunoassays have gained popularity across the medical industry. Physical measurements pertaining to immunoassays are under review, and favourable results could contribute to the growth of the market. The medical research industry is continually scouting for new technologies that can help in improving the performance of immunoassays. The application of protein-analysis in key domains within healthcare has played to the advantage of the immunoassay market.

Use of Immunoassays for Clinical Tests and Key Treatment Lines

The detection of analytes through immunoassays has helped the medical industry in fostering quality across primary treatment lines. Several types of clinical tests involve the use of immunoassay techniques, also known as immunodiagnostic tests. The use of immunoassays for pregnancy detection at home has emerged as an important driver of demand within the global market. Until a decade ago, there was widespread contention related to the accuracy of immunoassay tests. However, in recent times, the medical fraternity has acknowledged the use of immunoassay as medical markers. The use of immunoassay to measure insulin levels and diagnose heart diseases has also gained momentum in recent times. A number of pharmaceutical entities and research labs use immunoassay to test key compounds. On account of the factors mentioned herein, it is legit to expect that the global immunoassay market would grow at a sturdy pace in the times to follow.

Rising Incidence of Various Forms of Cancers

The use of immunoassays for diagnosing cancers has emerged as a vital driver of demand within the global market. The high incidence of cancer across several regional pockets has raised concerns across medical circles. Use of immunoassay for diagnosing prostate cancer has increased, mainly due to the ease of assessing prostate-specific antigens and hypoglycaemia through immunoassays. Over the course of the next decade, the total volume of revenues within the global immunoassay market is set to multiply. Assessment of heart disease can also be done with the help of specialised immunoassays.

Anti-Doping Analysis for Sportspersons

Doping is a severe crime in the sports fraternity, and sportspersons are required to steer clear and clean of doping tests. The consumption of restricted drugs and power boosters for sportspersons follows from several rules and regulations. Therefore, it is important to set up anti-doping analysis laboratories to test samples of players. The use of recombinant human growth hormone can result in increased power and skill in sportspersons. Therefore, medical professionals use immunoassays for conducting anti-doping tests. The demand graph of the global immunoassay market is set to escalate in the times to follow. The popularity of photoacoustic immunoassays is set to given an impetus to market growth and maturity.

The leading vendors operating in the global immunoassay market are focusing on developing multiple-marker technologies. The development of customized immunoassays that can help in diagnosing cancers, heart diseases, and other problems shall help market players in capturing new markets. The relevance of immunoassays across multiple medical domains shall propel sales across the market. Some of the leading players operating in the global immunoassay market are Dickinson and Company, Abbott Laboratories, Ortho Clinical Diagnostics, F. Hoffmann-La Roche Ltd., and Danaher Corporation.

Immunoassay Market – Overview

This report on the immunoassay market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in manufacturing, commercializing, and providing immunoassays and new entrants planning to enter the market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments considered in the scope of the study. This section also provides the overall information and data analysis of the global immunoassay market regarding leading market segments based on technology, product, application, end-user, and region.

The global immunoassay market has been classified based on technology, product, application, end-user, and region. Based on product, the global market has been segmented into chemiluminescence immunoassay (CLIA), enzyme-linked immunoassay (ELISA), enzyme-linked immunofluorescent assay (ELFA), radioimmunoassay (RIA), and others. In terms of product, the market has been categorized into analyzer and consumables. Based on application, the global immunoassay market has been divided into infectious disease, endocrinology, oncology, cardiology, orthopedics, and others. In terms of end-user, the market has been segmented into hospitals and diagnostics laboratories, blood banks, and others.

Each of the market segments have been extensively divided based on market-related factors such as rise in incidence rate and prevalence of acute, chronic, and infectious diseases; technological advancements in health care diagnostics; and emerging trends in the health care, pharmaceutical, and biotechnology industries. Moreover, historical year-on-year growth has been taken into consideration while estimating the market size. The market size and forecast in terms of US$ Mn for each segment has been provided for the period from 2016 to 2026. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2018 to 2026, considering 2017 as the base year.

The market overview section of the report explores market dynamics such as drivers, restraints, opportunities, and key trends that have a strong impact on the immunoassay market and could influence it in the near future. Market attractiveness analysis has been provided in an overview section to explain the intensity of competition in the market across different regions. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. These factors are likely to help market players take strategic decisions to strengthen their positions and expand their shares in the global immunoassay market.

Based on region, the immunoassay market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market size and forecast for each of these regions has been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The report also provides market size and forecast for major countries with each product and end-user in the respective regions. A detailed qualitative analysis of factors responsible for driving and restraining the market growth and future opportunities has been provided in the market overview section. This section of the report also provides the market attractiveness analysis and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global immunoassay market.

Major players operating in the global Immunoassay market are F. Hoffmann-La Roche AG, Danaher Corporation, Abbott Laboratories, Siemens Healthineers (Siemens AG), Thermo Fisher Scientific Inc., Merck KGaA, Becton, Dickinson and Company, Ortho Clinical Diagnostics (a part of Carlyle Group), bioMérieux SA, Sysmex Corporation, and DiaSorin S.p.A..

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

The global Immunoassay market is segmented as follows:

Technology

  • Chemiluminescence Immunoassay (CLIA)
  • Enzyme-linked Immunoassay (ELISA)
  • Enzyme-linked Immunofluorescent Assay (ELFA)
  • Radioimmunoassay (RIA)
  • Others

Product

  • Analyzer
  • Consumables

Application

  • Infectious Disease
  • Endocrinology
  • Oncology
  • Cardiology
  • Orthopedics
  • Others

End-user

  • Hospitals and Diagnostics Laboratories
  • Blood Banks
  • Others

Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America (LATAM)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.

TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.

Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:

Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.

Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.

Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Chapter 1  Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

Chapter 2  Assumptions and Research Methodology

Chapter 3  Executive Summary: Global Immunoassay Market                              

Chapter 4  Market Overview
4.1. Introduction
4.2. Key Industry Developments

Chapter 5  Market Dynamics
5.1. Drivers
5.2. Restraints
5.3. Opportunities
5.4. Key Trends
5.5. Global Immunoassay Market Size (US$ Mn) Forecast, 2016–2026
5.6. Global Immunoassay Market Outlook
5.7. Industry Mergers & Acquisitions
5.8. Automate Immunoassay Analyzer Volume
5.9. Distributor Analysis
5.10. Regulatory Assessments, by Key Country/Region
5.11. Winning Imperatives

Chapter 6  Global Immunoassay Market Analysis and Forecast, by Technology
6.1. Key Findings 
6.2. Introduction 
6.3. Market Size (US$ Mn) Forecast, by Technology, 2018–2026
       6.3.1. Chemiluminescence Immunoassay (CLIA) 
       6.3.2. Enzyme-linked Immunosorbent Assay (ELISA)
       6.3.3. Enzyme-linked Fluorescent Assay (ELFA)
       6.3.4. Radioimmunoassay (RIA)
       6.3.5. Others ( Microarray, Immunofluorescence Assay Biochip Assay, Counting Immunoassay) 
6.4. Market Attractiveness Analysis, by Technology

Chapter 7  Global Immunoassay Market Analysis and Forecast, by Product
7.1. Key Findings 
7.2. Introduction 
7.3. Market Size (US$ Mn) Forecast, by Product, 2018–2026
       7.3.1. Analyzer 
       7.3.2. Consumables 
7.4. Market Attractiveness Analysis, by Product

Chapter 8  Global Immunoassay Market Analysis and Forecast, by Application
8.1. Key Findings 
8.2. Introduction 
8.3. Market Size (US$ Mn) Forecast, by Application, 2018–2026
       8.3.1. Infectious Disease
       8.3.2. Endocrinology
       8.3.3. Oncology
       8.3.4. Cardiology
       8.3.5. Orthopedics
       8.3.6. Others (Autoimmune Disorders, Allergy, Therapeutic Drug Monitoring, Liver Diseases, Acid Base Tests, GI Stool Testing, etc.) 
8.4. Market Attractiveness Analysis, by Application

Chapter 9  Global Immunoassay Market  Analysis and Forecasts, by End-user
9.1. Key Findings
9.2. Market Size (US$ Mn) Forecast, by End-user, 2018–2026
       9.2.1. Hospitals and Diagnostics Laboratories
       9.2.2. Blood Banks
       9.2.3. Others (Academic & Research Institutes, Pharmaceutical & Biotech Companies)
9.3. Market Attractiveness Analysis, by End-user

Chapter 10  Global Immunoassay Market Analysis and Forecasts, by Region
10.1.  Key Findings
10.2.  Global Market Scenario
10.3. Market Value (US$ Mn) Forecast, by Region, 2018–2026
       10.3.1. North America
       10.3.2. Europe
       10.3.3. Asia Pacific 
       10.3.4. Latin America
       10.3.5. Middle East & Africa
10.4. Market Attractiveness Analysis, by Region
10.5. Key Trends, by Region

Chapter 11  North America Immunoassay  Market  Analysis and Forecast
11.1. Market Overview
11.2. Market Size  (US$ Mn) Forecast, by Country, 2018–2026
       11.2.1. U.S.
       11.2.2. Canada
11.3. Market Size (US$ Mn) Forecast, by Technology, 2018–2026
       11.3.1. Chemiluminescence Immunoassay (CLIA) 
       11.3.2. Enzyme-linked Immunosorbent Assay (ELISA)
       11.3.3. Enzyme Linked Fluorescent Assay (ELFA)
       11.3.4. Radioimmunoassay (RIA)
       11.3.5. Others 
11.4. Market Size (US$ Mn) Forecast, by Product, 2018–2026
       11.4.1. Analyzers
       11.4.2. Consumables
11.5.  Market Size (US$ Mn) Forecast, by Application, 2018–2026
       11.5.1. Infectious Disease
       11.5.2. Endocrinology
       11.5.3. Oncology
       11.5.4. Cardiology
       11.5.5. Orthopedics
       11.5.6. Others 
11.6. Market Size (US$ Mn) Forecast, by End-user, 2018–2026
       11.6.1. Hospitals and Diagnostics Laboratories
       11.6.2. Blood Banks
       11.6.3. Others
11.7. Market Attractiveness Analysis 
       11.7.1. By Country
       11.7.2. By Technology
       11.7.3. By Product
       11.7.4. By Application
       11.7.5. By End-user

Chapter 12  Europe Immunoassay  market  Analysis and Forecast
12.1. Market Overview
12.2. Market Size (US$ Mn) Forecast, by Country/Sub-region, 2018–2026
       12.2.1. U.K.
       12.2.2. Germany
       12.2.3. France
       12.2.4. Italy
       12.2.5. Spain
       12.2.6. Rest of Europe
12.3. Market Size (US$ Mn) Forecast, by Technology, 2018–2026
       12.3.1. Chemiluminescence Immunoassay (CLIA) 
       12.3.2. Enzyme-linked Immunosorbent Assay (ELISA)
       12.3.3. Enzyme Linked Fluorescent Assay (ELFA)
       12.3.4. Radioimmunoassay (RIA)
       12.3.5. Others 
12.4. Market Size (US$ Mn) Forecast, by Product, 2018–2026
       12.4.1. Analyzers
       12.4.2. Consumables
12.5.  Market Size (US$ Mn) Forecast, by Application, 2018–2026
       12.5.1. Infectious Disease
       12.5.2. Endocrinology
       12.5.3. Oncology
       12.5.4. Cardiology
       12.5.5. Orthopedics
       12.5.6. Others 
12.6. Market Size (US$ Mn) Forecast, by End-user, 2018–2026
       12.6.1. Hospitals and Diagnostics Laboratories
       12.6.2. Blood Banks
       12.6.3. Others
12.7. Market Attractiveness Analysis 
       12.7.1. By Country
       12.7.2. By Technology
       12.7.3. By Product
       12.7.4. By Application
       12.7.5. By End-user

Chapter 13  Asia Pacific Immunoassay Market Analysis and Forecast
13.1. Market Overview
13.2. Market Size (US$ Mn) Forecast, by Country/Sub-region, 2018–2026
       13.2.1. China
       13.2.2. India
       13.2.3. Japan
       13.2.4. Australia & New Zealand
       13.2.5. Rest of Asia Pacific
13.3. Market Size (US$ Mn) Forecast, by Technology, 2018–2026
       13.3.1. Chemiluminescence Immunoassay (CLIA) 
       13.3.2. Enzyme-linked Immunosorbent Assay (ELISA)
       13.3.3. Enzyme Linked Fluorescent Assay (ELFA)
       13.3.4. Radioimmunoassay (RIA)
       13.3.5. Others 
13.4. Market Size (US$ Mn) Forecast, by Product, 2018–2026
       13.4.1. Analyzers
       13.4.2. Consumables
13.5.  Market Size (US$ Mn) Forecast, by Application, 2018–2026
       13.5.1. Infectious Disease
       13.5.2. Endocrinology
       13.5.3. Oncology
       13.5.4. Cardiology
       13.5.5. Orthopedics
       13.5.6. Others 
13.6. Market size (US$ Mn) Forecast, by End-user, 2018–2026
       13.6.1. Hospitals and Diagnostics Laboratories
       13.6.2. Blood Banks
       13.6.3. Others
13.7. Market Attractiveness Analysis 
       13.7.1. By Country
       13.7.2. By Technology
       13.7.3. By Product
       13.7.4. By Application
       13.7.5. By End-user

Chapter 14  Latin America Immunoassay Market Analysis and Forecast
14.1. Market Overview
14.2. Market Size (US$ Mn) Forecast, by Country/Sub-region, 2018–2026
       14.2.1. Brazil
       14.2.2. Mexico
       14.2.3. Rest of Latin America
14.3. Market Size (US$ Mn) Forecast, by Technology, 2018–2026
       14.3.1. Chemiluminescence Immunoassay (CLIA) 
       14.3.2. Enzyme-linked Immunosorbent Assay (ELISA)
       14.3.3. Enzyme Linked Fluorescent Assay (ELFA)
       14.3.4. Radioimmunoassay (RIA)
       14.3.5. Others 
14.4. Market Size (US$ Mn) Forecast, by Product, 2018–2026
       14.4.1. Analyzers
       14.4.2. Consumables
14.5.  Market Size (US$ Mn) Forecast, by Application, 2018–2026
       14.5.1. Infectious Disease
       14.5.2. Endocrinology
       14.5.3. Oncology
       14.5.4. Cardiology
       14.5.5. Orthopedics
       14.5.6. Others 
14.6. Market Size (US$ Mn) Forecast, by End-user, 2018–2026
       14.6.1. Hospitals and Diagnostics Laboratories
       14.6.2. Blood Banks
       14.6.3. Others
14.7. Market Attractiveness Analysis 
       14.7.1. By Country
       14.7.2. By Technology
       14.7.3. By Product
       14.7.4. By Application
       14.7.5. By End-user

Chapter 15  Middle East and Africa Immunoassay Market Analysis and Forecast
15.1. Market Overview
15.2. Market size (US$ Mn) Forecast, by Country/Sub-region, 2018–2026
       15.2.1. GCC Countries
       15.2.2. South Africa
       15.2.3. Rest of Middle East and Africa
15.3. Market Size (US$ Mn) Forecast, by Technology, 2018–2026
       15.3.1. Chemiluminescence Immunoassay (CLIA) 
       15.3.2. Enzyme-linked Immunosorbent Assay (ELISA)
       15.3.3. Enzyme Linked Fluorescent Assay (ELFA)
       15.3.4. Radioimmunoassay (RIA)
       15.3.5. Others 
15.4. Market Size (US$ Mn) Forecast, by Product, 2018–2026
       15.4.1. Analyzers
       15.4.2. Consumables
15.5.  Market Size (US$ Mn) Forecast, by Application, 2018–2026
       15.5.1. Infectious Disease
       15.5.2. Endocrinology
       15.5.3. Oncology
       15.5.4. Cardiology
       15.5.5. Orthopedics
       15.5.6. Others 
15.6. Market Size (US$ Mn) Forecast, by End-user, 2018–2026
       15.6.1. Hospitals and Diagnostics Laboratories
       15.6.2. Blood Banks
       15.6.3. Others
15.7. Market Attractiveness Analysis 
       15.7.1. By Country
       15.7.2. By Technology
       15.7.3. By Product
       15.7.4. By Application
       15.7.5. By End-user

Chapter 16  Competition Landscape
16.1. Global Immunoassay Market Share, by Company, 2017
16.2. Market Player – Competition Matrix (By Tier and Size of Companies)
16.3. Company Profiles
       16.3.1. F. Hoffmann-La Roche Ltd.
                 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                 16.3.1.2. Product Portfolio
                 16.3.1.3. SWOT Analysis
                 16.3.1.4. Financial Overview
                 16.3.1.5. Strategic Overview
       16.3.2. Danaher Corporation.  
                 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                 16.3.2.2. Product Portfolio
                 16.3.2.3. SWOT Analysis
                 16.3.2.4. Financial Overview
                 16.3.2.5. Strategic Overview
       16.3.3. Abbott Laboratories.
                 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                 16.3.3.2. Product Portfolio
                 16.3.3.3. SWOT Analysis
                 16.3.3.4. Financial Overview
                 16.3.3.5. Strategic Overview
       16.3.4. Siemens Healthineers (Siemens AG)
                 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                 16.3.4.2. Product Portfolio
                 16.3.4.3. SWOT Analysis
                 16.3.4.4. Financial Overview
                 16.3.4.5. Strategic Overview
       16.3.5. DiaSorin S.p.A.
                 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                 16.3.5.2. Product Portfolio
                 16.3.5.3. SWOT Analysis
                 16.3.5.4. Financial Overview
                 16.3.5.5. Strategic Overview
       16.3.6. Sysmex Corporation.
                 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                 16.3.6.2. Product Portfolio
                 16.3.6.3. SWOT Analysis
                 16.3.6.4. Financial Overview
                 16.3.6.5. Strategic Overview
       16.3.7. bioMérieux SA 
                 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
                 16.3.7.2. Product Portfolio
                 16.3.7.3. SWOT Analysis
                 16.3.7.4. Financial Overview
                 16.3.7.5. Strategic Overview
       16.3.8. Ortho Clinical Diagnostics (a part of Carlyle Group).
                 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
                 16.3.8.2. Product Portfolio
                 16.3.8.3. SWOT Analysis
                 16.3.8.4. Financial Overview
                 16.3.8.5. Strategic Overview
       16.3.9. Thermo Fisher Scientific, Inc.
                 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
                 16.3.9.2. Product Portfolio
                 16.3.9.3. SWOT Analysis
                 16.3.9.4. Financial Overview
                 16.3.9.5. Strategic Overview
       16.3.10. Becton, Dickinson and Company.
                 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
                 16.3.10.2. Product Portfolio
                 16.3.10.3. SWOT Analysis
                 16.3.10.4. Financial Overview
                 16.3.10.5. Strategic Overview
       16.3.11. Merck KGaA.
                 16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
                 16.3.11.2. Product Portfolio
                 16.3.11.3. SWOT Analysis
                 16.3.11.4. Financial Overview
                 16.3.11.5. Strategic Overview

List of Tables

Table 01: Global Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 02: Global Immunoassay Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 03: Global Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 04: Global Immunoassay Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 05: Global Immunoassay Market Size (US$ Mn) Forecast, by Region, 2016–2026
Table 06: North America Immunoassay Market Value (US$ Mn) Forecast, by Country, 2016–2026
Table 07: North America Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 08: North America Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 09: North America Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 10: North America Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 11: U.S. Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 12: U.S. Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 13: U.S. Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 14: U.S. Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 15: Canada Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 16: Canada Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 17: Canada Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 18: Canada Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 19: Europe Immunoassay Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 20: Europe Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 21: Europe Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 22: Europe Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 23: Europe Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 24: Germany Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 25: Germany Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 26: Germany Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 27: Germany Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 28: U.K. Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 29: U.K. Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 30: U.K. Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 31: U.K. Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 32: France Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 33: France Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 34: France Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 35: France Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 36: Italy Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 37: Italy Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 38: Italy Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 39: Italy Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 40: Spain Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 41: Spain Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 42: Spain Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 43: Spain Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 44: Asia Pacific Immunoassay Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 45: Asia Pacific Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 46: Asia Pacific Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 47: Asia Pacific Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 48: Asia Pacific Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 49: China Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 50: China Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 51: China Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 52: China Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 53: India Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 54: India Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 55: India Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 56: India Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 57: Japan Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 58: Japan Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 59: Japan Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 60: Japan Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 61: Australia & New Zealand Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 62: Australia & New Zealand Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 63: Australia & New Zealand Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 64: Australia & New Zealand Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 65: Latin America Immunoassay Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 66: Latin America Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 67: Latin America Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 68: Latin America Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 69: Latin America Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 70: Brazil Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 71: Brazil Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 72: Brazil Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 73: Brazil Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 74: Mexico Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 75: Mexico Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 76: Mexico Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 77: Mexico Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 78: Middle East & Africa Immunoassay Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 79: Middle East & Africa Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 80: Middle East & Africa Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 81: Middle East & Africa Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 82: Middle East & Africa Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 83: GCC Countries Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 84: GCC Countries Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 85: GCC Countries Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 86: GCC Countries Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 87: South Africa Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 88: South Africa Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 89: South Africa Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 90: South Africa Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026

List of Figures

Figure 01: Global Immunoassay Market Size (US$ Mn) Forecast, 2016–2026
Figure 03: Market Value Share, by Technology (2017)
Figure 04: Market Value Share, by Product (2017)
Figure 04: Market Value Share, by End-user (2017)
Figure 03: Market Value Share, by Application (2017)
Figure 04: Market Value Share, by Region (2017)
Figure 07: Global Immunoassay Market Value Share Analysis (US$ Mn), by Technology, 2017 and 2026
Figure 08: Global Immunoassay Market Attractiveness Analysis, by Technology, 2018–2026
Figure 09: Global Immunoassay Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Chemiluminescence Immunoassay, 2016–2026
Figure 10: Global Immunoassay Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Enzyme-linked Immunosorbent Assay, 2016–2026
Figure 11: Global Immunoassay Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Enzyme Linked Fluorescent Assay, 2016–2026
Figure 12: Global Immunoassay Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Radioimmunoassay, 2016–2026
Figure 13: Global Immunoassay Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
Figure 14: Global Immunoassay Market Value Share Analysis (US$ Mn), by Product, 2017 and 2026
Figure 15: Global Immunoassay Market Attractiveness Analysis, by Product, 2018–2026
Figure 16: Global Immunoassay Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Analyzer, 2016–2026
Figure 17: Global Immunoassay Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Consumables, 2016–2026
Figure 18: Global Immunoassay Market Value Share Analysis (US$ Mn), by Application, 2017 and 2026
Figure 19: Global Immunoassay Market Attractiveness Analysis, by Application, 2018–2026
Figure 20: Global Immunoassay Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Infectious Disease, 2016–2026
Figure 21: Global Immunoassay Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Oncology, 2015–2025
Figure 22: Global Immunoassay Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Oncology, 2016–2026
Figure 23: Global Immunoassay Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Cardiology, 2016–2026
Figure 24: Global Immunoassay Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Orthopedics, 2016–2026
Figure 25: Global Immunoassay Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2016–2026
Figure 26: Global Immunoassay Market Value Share Analysis (US$ Mn), by End-user, 2017 and 2026
Figure 27: Global Immunoassay Market Attractiveness Analysis, by End-user, 2018–2026
Figure 28: Global Immunoassay Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals & Diagnostic Laboratories, 2016–2026
Figure 29: Global Immunoassay Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Blood Banks, 2016–2026
Figure 30: Global Immunoassay Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
Figure 31: Global Immunoassay Market Value Share Analysis, by Region, 2017 and 2026 
Figure 32: Global Immunoassay Market Attractiveness Analysis, by Region, 2018–2026
Figure 33: North America Immunoassay Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2018–2026
Figure 34: North America Immunoassay Market Value Share Analysis (US$ Mn), by Country, 2017 and 2026
Figure 35: North America Immunoassay Market Attractiveness Analysis, by Country, 2018–2026
Figure 36: North America Immunoassay Market Value Share, by Technology, 2017 and 2025
Figure 37: North America Immunoassay Market Attractiveness, by Technology, 2018–2026
Figure 38: North America Immunoassay Market Value Share, by Product, 2017 and 2026
Figure 39: North America Immunoassay Market Attractiveness, by Product, 2018–2026
Figure 40: North America Immunoassay Market Value Share, by Application, 2017 and 2026
Figure 41: North America Immunoassay Market Attractiveness, by Application, 2018–2026
Figure 42: North America Immunoassay Market Value Share Analysis, by End-user, 2017 and 2026
Figure 43: North America Immunoassay Market Attractiveness Analysis, by End-user, 2018–2026
Figure 44: Europe Immunoassay Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2018–2026
Figure 45: Europe Immunoassay Market Value Share Analysis (US$ Mn), by Country/Sub-region, 2017 and 2026
Figure 46: Europe Immunoassay Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
Figure 47: Europe Immunoassay Market Value Share, by Technology, 2017 and 2025
Figure 48: Europe Immunoassay Market Attractiveness, by Technology, 2018–2026
Figure 49: Europe Immunoassay Market Value Share, by Product, 2017 and 2026
Figure 50: Europe Immunoassay Market Attractiveness, by Product, 2018–2026
Figure 51: Europe Immunoassay Market Value Share, by Application, 2017 and 2026
Figure 52: Europe Immunoassay Market Attractiveness, by Application, 2018–2026
Figure 53: Europe Immunoassay Market Value Share Analysis, by End-user, 2017 and 2026
Figure 54: Europe Immunoassay Market Attractiveness Analysis, by End-user, 2018–2026
Figure 55: Asia Pacific Immunoassay Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2018–2026
Figure 56: Asia Pacific Immunoassay Market Value Share Analysis (US$ Mn), by Country/Sub-region, 2017 and 2026
Figure 57: Asia Pacific Immunoassay Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
Figure 58: Asia Pacific Immunoassay Market Value Share, by Technology, 2017 and 2025
Figure 59: Asia Pacific Immunoassay Market Attractiveness, by Technology, 2018–2026
Figure 60: Asia Pacific Immunoassay Market Value Share, by Product, 2017 and 2026
Figure 61: Asia Pacific Immunoassay Market Attractiveness, by Product, 2018–2026
Figure 62: Asia Pacific Immunoassay Market Value Share, by Application, 2017 and 2026
Figure 63: Asia Pacific Immunoassay Market Attractiveness, by Application, 2018–2026
Figure 64: Asia Pacific Immunoassay Market Value Share Analysis, by End-user, 2017 and 2026
Figure 65: Asia Pacific Immunoassay Market Attractiveness Analysis, by End-user, 2018–2026
Figure 66: Latin America Immunoassay Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2018–2026
Figure 67: Latin America Immunoassay Market Value Share Analysis (US$ Mn), by Country/Sub-region, 2017 and 2026
Figure 68: Latin America Immunoassay Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
Figure 69: Latin America Immunoassay Market Value Share, by Technology, 2017 and 2025
Figure 70: Latin America Immunoassay Market Attractiveness, by Technology, 2018–2026
Figure 71: Latin America Immunoassay Market Value Share, by Product, 2017 and 2026
Figure 72: Latin America Immunoassay Market Attractiveness, by Product, 2018–2026
Figure 73: Latin America Immunoassay Market Value Share, by Application, 2017 and 2026
Figure 74: Latin America Immunoassay Market Attractiveness, by Application, 2018–2026
Figure 75: Latin America Immunoassay Market Value Share Analysis, by End-user, 2017 and 2026
Figure 76: Latin America Immunoassay Market Attractiveness Analysis, by End-user, 2018–2026
Figure 77: Middle East & Africa Immunoassay Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2018–2026
Figure 78: Middle East & Africa Immunoassay Market Value Share Analysis (US$ Mn), by Country/Sub-region, 2017 and 2026
Figure 79: Middle East & Africa Immunoassay Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
Figure 80: Middle East & Africa Immunoassay Market Value Share, by Technology, 2017 and 2025
Figure 81: Middle East & Africa Immunoassay Market Attractiveness, by Technology, 2018–2026
Figure 82: Middle East & Africa Immunoassay Market Value Share, by Product, 2017 and 2026
Figure 83: Middle East & Africa Immunoassay Market Attractiveness, by Product, 2018–2026
Figure 84: Middle East & Africa Immunoassay Market Value Share, by Application, 2017 and 2026
Figure 85: Middle East & Africa Immunoassay Market Attractiveness, by Application, 2018–2026
Figure 86: Middle East & Africa Immunoassay Market Value Share Analysis, by End-user, 2017 and 2026
Figure 87: Middle East & Africa Immunoassay Market Attractiveness Analysis, by End-user, 2018–2026
Figure 88: Global Immunoassay Market Share Analysis, by Company (2017)

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Immunoassay Market